Coronary Artery Disease
Late stent thrombosis in the nonbrachytherapy population: A real phenomenon?
Ivan P. Casserly,
Jeffrey A. Goldstein MD,
John M. Lasala MD, PhD,
Corresponding Author
Ivan P. Casserly
Division of Cardiovascular Medicine, Barnes-Jewish Hospital, Washington University School of Medicine, Saint Louis, Missouri
Division of Cardiovascular Medicine, Barnes-Jewish Hospital, 660 South Euclid Avenue, Box 8086, Saint Louis, Missouri 63110Search for more papers by this authorJeffrey A. Goldstein MD
Division of Cardiovascular Medicine, Barnes-Jewish Hospital, Washington University School of Medicine, Saint Louis, Missouri
Search for more papers by this authorJohn M. Lasala MD, PhD
Division of Cardiovascular Medicine, Barnes-Jewish Hospital, Washington University School of Medicine, Saint Louis, Missouri
Search for more papers by this authorIvan P. Casserly,
Jeffrey A. Goldstein MD,
John M. Lasala MD, PhD,
Corresponding Author
Ivan P. Casserly
Division of Cardiovascular Medicine, Barnes-Jewish Hospital, Washington University School of Medicine, Saint Louis, Missouri
Division of Cardiovascular Medicine, Barnes-Jewish Hospital, 660 South Euclid Avenue, Box 8086, Saint Louis, Missouri 63110Search for more papers by this authorJeffrey A. Goldstein MD
Division of Cardiovascular Medicine, Barnes-Jewish Hospital, Washington University School of Medicine, Saint Louis, Missouri
Search for more papers by this authorJohn M. Lasala MD, PhD
Division of Cardiovascular Medicine, Barnes-Jewish Hospital, Washington University School of Medicine, Saint Louis, Missouri
Search for more papers by this author
REFERENCES
- 1 Berger PB, Bell MR, Rihal CS, et al. Clopidogrel versus ticlopidine after intracoronary stent placement. J Am Coll Cardiol 1999; 34: 1891–1894.
- 2 Mishkel GJ, Aguirre FV, Ligon RW, Rocha-Singh KJ, Lucore CL. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting. J Am Coll Cardiol 1999; 34: 1884–1890.
- 3 Moussa I, Oetgen M, Roubin G, et al. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation 1999; 99: 2364–2366.
- 4 Kolansky DM, Klugherz BD, Curran SC, et al. Combination therapy with clopidogrel and aspirin after coronary stenting. Cathet Cardiovasc Intervent 2000; 50: 276–279.
- 5 Muller C, Buttner HJ, Petersen J, Roskamm H. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. Circulation 2000; 101: 590–593.
- 6 Taniuchi M, Kurz HI, Lasala JM. Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population. Circulation 2001; 104: 539–543.
- 7 Wilson SH, Rihal CS, Bell MR, Velianou JL, Holmes DR Jr, Berger PB. Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin. Am J Cardiol 1999; 83: 1006–1011.
- 8 Berger PB, Bell MR, Hasdai D, Grill DE, Melby S, Holmes DR Jr. Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement. Circulation 1999; 99: 248–253.
- 9 Cutlip DE. Stent thrombosis: historical perspectives and current trends. J Thromb Thrombolysis 2000; 10: 89–101.
- 10 Waksman R, Bhargava B, Mintz GS, et al. Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. J Am Coll Cardiol 2000; 36: 65–68.
- 11 Waksman R. Late thrombosis after radiation: sitting on a time bomb. Circulation 1999; 100: 780–782.
- 12 Raizner AE, Oesterle SN, Waksman R, et al. Inhibition of restenosis with beta-emitting radiotherapy: report of the Proliferation Reduction With Vascular Energy Trial (PREVENT). Circulation 2000; 102: 951–958.
- 13 Costa MA, Sabat M, van der Giessen WJ, et al. Late coronary occlusion after intracoronary brachytherapy. Circulation 1999; 100: 789–792.
- 14 Wang F, Stouffer GA, Waxman S, Uretsky BF. Late coronary stent thrombosis: early vs. late stent thrombosis in the stent era. Cathet Cardiovasc Intervent 2002; 55: 142–147.
- 15 Ho KKL, Cutlip DE, Cohen DJ, et al. The incidence of late stent thrombosis without the use of brachytherapy. J Am Coll Cardiol 2000; 35: 77A.
- 16 Heller LI, Shemwell KC, Hug K. Late stent thrombosis in the absence of prior intracoronary brachytherapy. Cathet Cardiovasc Intervent 2001; 53: 23–28.
- 17 Waksman R, Ajani AE, White RL, et al. Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial Plus 6 Months of Clopidogrel (WRIST PLUS). Circulation 2001; 103: 2332–2335.
- 18 La Vecchia L, Bedogni F, Vincenzi M. Subacute stent thrombosis occurring more than one month after implantation for acute myocardial infarction: description of two cases successfully treated with angioplasty and further stenting. Cardiology 1998; 90: 305–308.
- 19 Liistro F, Colombo A. Late acute thrombosis after paclitaxel eluting stent implantation. Heart 2001; 86: 262–264.
- 20 Kalaria VG, Ling FS. Late stent thrombosis without antecedent brachytherapy: confirmation and treatment with rheolytic thrombectomy. Cathet Cardiovasc Intervent 2001; 53: 243–247.
- 21 Kwok OH, Ng W, Chow WH. Late stent thrombosis after successful rescue of a major coronary artery rupture with a polytetrafluoroethylene-covered stent. J Invas Cardiol 2001; 13: 391–394.
- 22 Mak KH, Belli G, Ellis SG, Moliterno DJ. Subacute stent thrombosis: evolving issues and current concepts. J Am Coll Cardiol 1996; 27: 494–503.
- 23 Rau T, Schofer J, Schluter M, Seidensticker A, Berger J, Mathey DG. Stenting of nonacute total coronary occlusions: predictors of late angiographic outcome. J Am Coll Cardiol 1998; 31: 275–280.
- 24 Bauters C, Hubert E, Prat A, et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 1998; 31: 1291–1298.
- 25 Siegel RJ, Ariani M, Fishbein MC, et al. Histopathologic validation of angioscopy and intravascular ultrasound. Circulation 1991; 84: 109–117.
- 26 Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation 2001; 103: 604–616.
- 27 Cutlip DE, Baim DS, Ho KK, et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001; 103: 1967–1971.
- 28 Moussa I, Di Mario C, Reimers B, Akiyama T, Tobis J, Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol 1997; 29: 6–12.
- 29 Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol 2000; 35: 157–163.
- 30 Baldus S, Koster R, Elsner M, et al. Treatment of aortocoronary vein graft lesions with membrane-covered stents: a multicenter surveillance trial. Circulation 2000; 102: 2024–2027.
- 31 Briguori C, Nishida T, Anzuini A, Di Mario C, Grube E, Colombo A. Emergency polytetrafluoroethylene-covered stent implantation to treat coronary ruptures. Circulation 2000; 102: 3028–3031.
- 32 Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 2001; 104: 2007–2011.
- 33 Randomized trial evaluting TAXUS paclitaxel-eluting stent in de-novo coronary lesions and in-stent restenosis. American Heart Association Meeting. Anaheim; 2001.
- 34 Morice M, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773–1780.
- 35 Asian pacliltaxel-eluting stent clinical trial. Transcatheter Cardiovascular Therapeutics Meeting. Washington, DC; 2001.
- 36 European evaluation of paclitaxel elulting stent. American Heart Association. Anaheim; 2001.
- 37 Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358: 527–533.
- 38 Steinhubl SR, Berger PB, Mann JT, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. A randomized controlled trial. JAMA 2002; 288: 2411–2420.
